Finch Therapeutics

Finch Therapeutics Focuses on Developing Novel Microbiome Therapies to Serve Patients with Significant Unmet Medical Needs. Founded by Data Scientists, Clinicians, and Microbiologists from MIT and OpenBiome, this rising company employs innovative machine learning algorithms to reverse-engineer successful clinical microbiome therapies based on high-throughput microbial molecular data. These innovative therapies are rooted in the science of fecal transplantation. Finch uses this human-first microbiology approach to identify and develop strains with clinical benefits and deliver these microbial communities to patients.